Use of OxyContin profits to fight opioids formally approved
By GEOFF MULVIHILL Associated Press A judge formally approved a plan Friday to turn OxyContin maker Purdue Pharma into a new company no longer owned by members of the Sackler family and with its profits going to fight the opioid epidemic. A U.S. bankruptcy court judge signed the plan Friday, more than two weeks after
Continue Reading